Cahn A, Wiviott SD, Mosenzon O, Murphy SA, et al. Cardiorenal outcomes with dapagliflozin by baseline glucose-lowering agents: Post hoc analyses from DECLARE-TIMI 58. Diabetes Obes Metab 2021;23:29-38.
PMID: 32844557